Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Sugammadex on EEG-derived Index Values
NCT01142648Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Behaviour of depth of anaesthesia indexes (BIS, SE, RE) at 30 minutes. Started Apr 2009; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01142648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142648.